MB, Levis & Associates’s Eli Lilly LLY Stock Holding History

MB, Levis & Associates’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$115K	Hold	125	–	–	0.05%	74
2025 Q4	$135K	Hold	125	–	–	0.06%	68
2025 Q3	$95.5K	Sell	125 -66	-35%	-$49.1K	0.04%	84
2025 Q2	$149K	Buy	191 +29	+18%	+$22.5K	0.07%	74
2025 Q1	$134K	Hold	162	–	–	0.06%	75
2024 Q4	$125K	Sell	162 -4	-2%	-$3.31K	0.06%	77
2024 Q3	$147K	Hold	166	–	–	0.07%	70
2024 Q2	$150K	Hold	166	–	–	0.08%	68
2024 Q1	$129K	Buy	166 +36	+28%	+$25.6K	0.07%	72
2023 Q4	$76.1K	Hold	130	–	–	0.04%	94
2023 Q3	$70K	Hold	130	–	–	0.05%	95
2023 Q2	$61.1K	Hold	130	–	–	0.04%	105
2023 Q1	$44.7K	Hold	130	–	–	0.03%	115
2022 Q4	$47.6K	Buy	+130	New	+$46.1K	0.04%	109

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

MB, Levis & Associates's LLY Position: Q1 2026 in Review

MB, Levis & Associates held its Eli Lilly (LLY) position steady in Q1 2026 at 125 shares worth $115K. The position accounts for 0.05% of the portfolio, ranked #74.

MB, Levis & Associates first reported a position in LLY in Q4 2022 and has held it in 14 quarters since. The position peaked at $150K in Q2 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

MB, Levis & Associates held 125 shares of Eli Lilly worth $115K as of Q1 2026.
MB, Levis & Associates left its Eli Lilly share count unchanged in Q1 2026.
Eli Lilly made up 0.05% of MB, Levis & Associates's portfolio in Q1 2026, its #74 holding.
MB, Levis & Associates first reported a position in Eli Lilly in Q4 2022 and has held it in 14 quarters since.
MB, Levis & Associates's Eli Lilly position peaked at $150K in Q2 2024.
4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on MB, Levis & Associates's 13F filing for Q1 2026, filed 8 Apr 2026.